Patents by Inventor Kenneth Savin

Kenneth Savin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of epothilones, intermediates thereto, analogues and uses thereof
    Publication number: 20080004450
    Abstract: The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof. Also provided are analogues related to epothilone A and B and intermediates useful for preparing same. The present invention further provides novel compositions based on analogues of the epothilones and methods for the treatment of cancer and cancer which has developed a multidrug-resistant phenotype.
    Type: Application
    Filed: January 11, 2007
    Publication date: January 3, 2008
    Inventors: Samuel Danishefsky, Peter Bertinato, Dai-Shi Su, Dong Meng, Ting-Chao Chou, Ted Kamenecka, Erik Sorensen, Aaron Balog, Kenneth Savin
  • Tachykinin receptor antagonists
    Publication number: 20060160794
    Abstract: The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
    Type: Application
    Filed: June 3, 2004
    Publication date: July 20, 2006
    Inventors: Albert Amegadzie, Kevin Gardinier, Erik Hembre, Philip Hipskind, Louis Jungheim, Brian Muehl, Kenneth Savin, Keneth Thrasher, Steven Boyd
  • Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
    Publication number: 20050272718
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Application
    Filed: May 6, 2003
    Publication date: December 8, 2005
    Inventors: Jochen Ammenn, James Gillig, Lawrence Heinz, Philip Hipskind, Michael Kinnick, Yen-Shi Lai, John Morin, James Nixon, Carsten Ott, Kenneth Savin, Theo Schotten, Lawrence Slieker, Nancy Snyder, Michael Robertson
  • Tachykinin receptor antagonists
    Publication number: 20050239776
    Abstract: The present invention relates to selective NK-1 receptor antagonists of Formula (I); or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
    Type: Application
    Filed: April 22, 2003
    Publication date: October 27, 2005
    Applicant: Eli Lilly and Company
    Inventors: Albert Amegadzie, Kevin Gardinier, Erik Hembre, Jian Hong, Louis Jungheim, Brian Muehl, David Remick, Michael Robertson, Kenneth Savin
  • Triazole derivatives as tachykinin receptor antagonists
    Publication number: 20050239786
    Abstract: This application relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and its use as an inhibitor of the NK-1 subtype of tachykinin receptors, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: April 22, 2003
    Publication date: October 27, 2005
    Applicant: Eli Lilly Company
    Inventors: Albert Amegadzie, Kevin Gardinier, Erik Hembre, Jian Hong, Louis Jungheim, Brian Muehl, David Remick, Michael Robertson, Kenneth Savin
  • Synthesis of epothilones, intermediates thereto, analogues and uses thereof
    Publication number: 20050043376
    Abstract: The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof. Also provided are analogues related to epothilone A and B and intermediates useful for preparing same. The present invention further provides novel compositions based on analogues of the epothilones and methods for the treatment of cancer and cancer which has developed a multidrug-resistant phenotype.
    Type: Application
    Filed: December 2, 2003
    Publication date: February 24, 2005
    Inventors: Samuel Danishefsky, Peter Bertinato, Dai-Shi Su, Dongfang Meng, Ting-Chao Chou, Ted Kamenecka, Erik Sorensen, Aaron Balog, Kenneth Savin
  • Synthesis of epothilones, intermediates thereto, analogues and uses thereof
    Publication number: 20050033059
    Abstract: The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof. Also provided are analogues related to epothilone A and B and intermediates useful for preparing same. The present invention further provides novel compositions based on analogues of the epothilones and methods for the treatment of cancer and cancer which has developed a multidrug-resistant phenotype.
    Type: Application
    Filed: December 4, 2001
    Publication date: February 10, 2005
    Inventors: Samuel Danishefsky, Peter Bertinato, Dai-Shi Su, Dang Fang Meng, Ting-Chao Chou, Ted Kamenecka, Erik Sorensen, Aaron Balog, Kenneth Savin